Information  X 
Enter a valid email address

Lamprell plc (LAM)

  Print      Mail a friend       Annual reports

Monday 09 December, 2019

Lamprell plc

Debt Facility Extension

RNS Number : 2381W
Lamprell plc
09 December 2019
 

 

9 December 2019

 

 

LAMPRELL PLC
("Lamprell" and with its subsidiaries the "Group")

 

DEBT FACILITY EXTENSION

 

 

Lamprell announces that it has today agreed an extension to its current debt facility of USD 30 million until 14 April 2020.

 

Discussions with a syndicate of international banks in respect of a new banking facility are ongoing and we will provide an update as soon as appropriate.

 

Lamprell will provide a trading update on its performance on 16th January 2020.

 

 

- Ends -

 

 

Enquiries:

 

Lamprell plc

 

Maria Babkina, Investor Relations

+44 (0) 7852 618 046



 


Tulchan Communications, London

+44 (0) 207 353 4200

Martin Robinson


Martin Pengelley




 

Notes to editors

Lamprell PLC, based in the United Arab Emirates ("UAE") and with over 40 years' experience, is a leading provider of fabrication, engineering and contracting services to the offshore and onshore oil & gas and renewable energy industries.  The Group has established leading market positions in the fabrication of shallow-water drilling jackup rigs, liftboats, land rigs, and rig refurbishment projects, and it also has an international reputation for building complex offshore and onshore process modules and fixed platforms.

 

Lamprell employs around 4,000 people across multiple facilities, with its primary facilities located in Hamriyah, Sharjah and Jebel Ali, all of which are in the UAE. In addition, the Group has facilities in Saudi Arabia (through a joint venture agreement). Combined, the Group's facilities cover approximately 828,000 m2 with 1.6 km of quayside.

 

Lamprell is listed on the London Stock Exchange (symbol "LAM").


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCBDBDDRUGBGCC

a d v e r t i s e m e n t